Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 13.3B | 15.1B | 14.5B | 14.5B |
| Cost of revenue | 4.0B | 4.4B | 4.2B | 4.2B |
| Gross profit | 9.3B | 10.7B | 10.2B | 10.3B |
| Operating expense | ||||
| Research & development | 2.1B | 6.8B | 2.1B | 1.9B |
| Selling general and admin | 3.3B | 3.9B | 4.2B | 3.4B |
| Other operating expenses | — | — | — | — |
| Operating income | 4.0B | 84M | 3.9B | 4.9B |
| Non operating interest income | ||||
| Income | 73M | 92M | 129M | 220M |
| Expense | 700M | 702M | 720M | 726M |
| Other income expense | -1.7B | -1.7B | -1.2B | -2.3B |
| Pretax income | 1.7B | -2.3B | 2.1B | 2.1B |
| Tax provision | 372M | -2.2B | 520M | 773M |
| Net income | 1.3B | -23M | 1.6B | 1.4B |
| Basic EPS | 0.7 | 0.0 | 0.9 | 0.8 |
| Diluted EPS | 0.7 | 0.0 | 0.9 | 0.8 |
| Basic average shares | 1.5M | 1.5M | 1.5M | 1.5M |
| Diluted average shares | 1.6M | 1.5M | 1.6M | 1.5M |
| EBITDA | 4.7B | 2.1B | 5.0B | 5.9B |
| Net income from continuing op. | 1.3B | -23M | 1.6B | 1.4B |
| Minority interests | -3M | 1M | -3M | -3M |
| Preferred stock dividends | 10M | 10M | 10M | 10M |